{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:24:03Z","timestamp":1789658643715,"version":"4.0.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research Project of Fujian Education Department","award":["JZ230018"],"award-info":[{"award-number":["JZ230018"]}],"id":[{"id":"https:\/\/ror.org\/01d6wrk87","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"DOI":"10.1007\/s00204-026-04534-5","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:23:20Z","timestamp":1789647800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Doxorubicin-induced hepatotoxicity: a multifaceted pathogenesis from mitochondrial collapse to immune remodeling and epigenetic memory"],"prefix":"10.1007","author":[{"given":"Bohuai","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0793-1361","authenticated-orcid":false,"given":"Zengbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"4534_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115010","volume":"165","author":"FA Alherz","year":"2023","unstructured":"Alherz FA, Negm WA, El-Masry TA, Elmorshedy KE, El-Kadem AH (2023) The potential beneficial role of Ginkgetin in doxorubicin-induced hepatotoxicity: elucidating the underlying claim. Biomed Pharmacother 165:115010. https:\/\/doi.org\/10.1016\/j.biopha.2023.115010","journal-title":"Biomed Pharmacother"},{"key":"4534_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112594","volume":"146","author":"WH Al-Qahtani","year":"2022","unstructured":"Al-Qahtani WH, Alshammari GM, Ajarem JS et al (2022) Isoliquiritigenin prevents Doxorubicin-induced hepatic damage in rats by upregulating and activating SIRT1. Biomed Pharmacother 146:112594. https:\/\/doi.org\/10.1016\/j.biopha.2021.112594","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"4534_CR3","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s12032-025-03113-5","volume":"42","author":"N Asgari","year":"2025","unstructured":"Asgari N, Kalhori Z (2025) Empagliflozin mitigates doxorubicin-induced hepatotoxicity by reducing inflammation, oxidative stress, and apoptosis in male NMRI mice. Med Oncol 42(12):542. https:\/\/doi.org\/10.1007\/s12032-025-03113-5","journal-title":"Med Oncol"},{"key":"4534_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8296451","author":"BM Barakat","year":"2018","unstructured":"Barakat BM, Ahmed HI, Bahr HI, Elbahaie AM (2018) Protective effect of Boswellic acids against doxorubicin-induced hepatotoxicity: impact on Nrf2\/HO-1 defense pathway. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2018\/8296451","journal-title":"Oxid Med Cell Longev"},{"key":"4534_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246291","author":"MA Bauer","year":"2021","unstructured":"Bauer MA, Todorova VK, Stone A et al (2021) Genome-wide DNA methylation signatures predict the early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13246291","journal-title":"Cancers (Basel)"},{"key":"4534_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1353029","author":"SR Botros","year":"2024","unstructured":"Botros SR, Matouk AI, Amin A, Heeba GH (2024) Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1\/Nrf2\/NF-\u03baB\/TNF-\u03b1 signaling pathways. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1353029","journal-title":"Front Pharmacol"},{"issue":"7","key":"4534_CR7","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1172\/jci61303","volume":"122","author":"A Caudrillier","year":"2012","unstructured":"Caudrillier A, Kessenbrock K, Gilliss BM et al (2012) Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 122(7):2661\u20132671. https:\/\/doi.org\/10.1172\/jci61303","journal-title":"J Clin Invest"},{"key":"4534_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cyto.2015.12.012","volume":"82","author":"Y Cepero-Donates","year":"2016","unstructured":"Cepero-Donates Y, Rakotoarivelo V, Mayhue M, Ma A, Chen YG, Ramanathan S (2016) Homeostasis of IL-15 dependent lymphocyte subsets in the liver. Cytokine 82:95\u2013101. https:\/\/doi.org\/10.1016\/j.cyto.2015.12.012","journal-title":"Cytokine"},{"key":"4534_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2024.153757","volume":"503","author":"M Chen","year":"2024","unstructured":"Chen M, Yi Y, Chen B et al (2024) Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice. Toxicology 503:153757. https:\/\/doi.org\/10.1016\/j.tox.2024.153757","journal-title":"Toxicology"},{"key":"4534_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116799","volume":"482","author":"F Cheng","year":"2024","unstructured":"Cheng F, Zhang Y, Xiong H et al (2024) NMNATs expression inhibition mediated NAD(+) deficiency plays a critical role in doxorubicin-induced hepatotoxicity in mice. Toxicol Appl Pharmacol 482:116799. https:\/\/doi.org\/10.1016\/j.taap.2023.116799","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"4534_CR11","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/clinchem\/34.5.890","volume":"34","author":"D Cotariu","year":"1988","unstructured":"Cotariu D, Zaidman JL (1988) Valproic acid and the liver. Clin Chem 34(5):890\u2013897","journal-title":"Clin Chem"},{"issue":"5","key":"4534_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/ijc.2910610520","volume":"61","author":"T Daemen","year":"1995","unstructured":"Daemen T, Hofstede G, Ten Kate MT, Bakker-Woudenberg IA, Scherphof GL (1995) Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages. Int J Cancer 61(5):716\u2013721. https:\/\/doi.org\/10.1002\/ijc.2910610520","journal-title":"Int J Cancer"},{"issue":"16","key":"4534_CR13","doi-asserted-by":"publisher","first-page":"7163","DOI":"10.7150\/thno.44960","volume":"10","author":"S Dai","year":"2020","unstructured":"Dai S, Liu F, Qin Z et al (2020) Kupffer cells promote T-cell hepatitis by producing CXCL10 and limiting liver sinusoidal endothelial cell permeability. Theranostics 10(16):7163\u20137177. https:\/\/doi.org\/10.7150\/thno.44960","journal-title":"Theranostics"},{"issue":"3","key":"4534_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4331\/wjbc.v5.i3.377","volume":"5","author":"AJ Dirks-Naylor","year":"2014","unstructured":"Dirks-Naylor AJ, Kouzi SA, Bero JD, Tran NT, Yang S, Mabolo R (2014) Effects of acute doxorubicin treatment on hepatic proteome lysine acetylation status and the apoptotic environment. World J Biol Chem 5(3):377\u2013386. https:\/\/doi.org\/10.4331\/wjbc.v5.i3.377","journal-title":"World J Biol Chem"},{"issue":"1","key":"4534_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY et al (2017) ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 13(1):91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239","journal-title":"Nat Chem Biol"},{"key":"4534_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165737","author":"M Dro\u017adzik","year":"2020","unstructured":"Dro\u017adzik M, Oswald S, Dro\u017adzik A (2020) Extrahepatic drug transporters in liver failure: focus on kidney and gastrointestinal tract. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21165737","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4534_CR17","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/ijc.28797","volume":"135","author":"S Durmus","year":"2014","unstructured":"Durmus S, Naik J, Buil L, Wagenaar E, van Tellingen O, Schinkel AH (2014) In vivo disposition of doxorubicin is affected by mouse Oatp1a\/1b and human OATP1A\/1B transporters. Int J Cancer 135(7):1700\u20131710. https:\/\/doi.org\/10.1002\/ijc.28797","journal-title":"Int J Cancer"},{"issue":"8","key":"4534_CR18","doi-asserted-by":"publisher","first-page":"10125","DOI":"10.1007\/s00210-025-03808-6","volume":"398","author":"AM El-Dessouki","year":"2025","unstructured":"El-Dessouki AM, Yousef EH, Raslan NA, Alwakeel AI, Ibrahim S, Alzokaky AA (2025) Febuxostat protects from doxorubicin induced hepatotoxicity in rats via regulation of NF-\u03baB p65\/NLRP3 inflammasome and SIRT-1\/AMPK pathways. Naunyn Schmiedebergs Arch Pharmacol 398(8):10125\u201310137. https:\/\/doi.org\/10.1007\/s00210-025-03808-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4534_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.tox.2017.08.011","volume":"390","author":"A Ferreira","year":"2017","unstructured":"Ferreira A, Cunha-Oliveira T, Sim\u00f5es RF et al (2017) Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity. Toxicology 390:63\u201373. https:\/\/doi.org\/10.1016\/j.tox.2017.08.011","journal-title":"Toxicology"},{"issue":"4","key":"4534_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41573-023-00877-1","volume":"23","author":"A Galetin","year":"2024","unstructured":"Galetin A, Brouwer KLR, Tweedie D et al (2024) Membrane transporters in drug development and as determinants of precision medicine. Nat Rev Drug Discov 23(4):255\u2013280. https:\/\/doi.org\/10.1038\/s41573-023-00877-1","journal-title":"Nat Rev Drug Discov"},{"issue":"supplement 1","key":"4534_CR21","first-page":"P449","volume":"64","author":"I Gertsenshteyn","year":"2023","unstructured":"Gertsenshteyn I, Bijari F, Moon S-H et al (2023) <strong>Early detection of doxorubicin-induced hepatotoxicity by imaging mitochondrial membrane potential<\/strong>. J Nucl Med 64(supplement 1):P449\u2013P449","journal-title":"J Nucl Med"},{"issue":"1","key":"4534_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2249.2004.02586.x","volume":"138","author":"L Golden-Mason","year":"2004","unstructured":"Golden-Mason L, Kelly AM, Doherty DG et al (2004) Hepatic interleuklin 15 (IL-15) expression: implications for local NK\/NKT cell homeostasis and development. Clin Exp Immunol 138(1):94\u2013101. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02586.x","journal-title":"Clin Exp Immunol"},{"key":"4534_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2023.153587","volume":"494","author":"X Guan","year":"2023","unstructured":"Guan X, Wang Y, Li W et al (2023) The effects and mechanism of LncRNA NORAD on doxorubicin-induced cardiotoxicity. Toxicology 494:153587. https:\/\/doi.org\/10.1016\/j.tox.2023.153587","journal-title":"Toxicology"},{"issue":"4","key":"4534_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4161\/epi.2.4.5214","volume":"2","author":"R Guerrero-Preston","year":"2007","unstructured":"Guerrero-Preston R, Santella RM, Blanco A, Desai M, Berdasco M, Fraga M (2007) Global DNA hypomethylation in liver cancer cases and controls: a phase I preclinical biomarker development study. Epigenetics 2(4):223\u2013226. https:\/\/doi.org\/10.4161\/epi.2.4.5214","journal-title":"Epigenetics"},{"key":"4534_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2025.102137","volume":"15","author":"N Hemmati","year":"2025","unstructured":"Hemmati N, Anoush M, Kiasari BA, Torkamani A (2025) Targeting ferroptosis as a therapeutic strategy for hepatotoxicity. Toxicol Rep 15:102137. https:\/\/doi.org\/10.1016\/j.toxrep.2025.102137","journal-title":"Toxicol Rep"},{"issue":"6","key":"4534_CR26","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1249\/mss.0000000000001887","volume":"51","author":"JM Hinkley","year":"2019","unstructured":"Hinkley JM, Morton AB, Ichinoseki-Sekine N, Huertas AM, Smuder AJ (2019) Exercise training prevents doxorubicin-induced mitochondrial dysfunction of the liver. Med Sci Sports Exerc 51(6):1106\u20131115. https:\/\/doi.org\/10.1249\/mss.0000000000001887","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"4534_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13238-012-2036-3","volume":"3","author":"J Hu","year":"2012","unstructured":"Hu J, Xu Y, Hao J, Wang S, Li C, Meng S (2012) MiR-122 in hepatic function and liver diseases. Protein Cell 3(5):364\u2013371. https:\/\/doi.org\/10.1007\/s13238-012-2036-3","journal-title":"Protein Cell"},{"issue":"1","key":"4534_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00726-023-03363-5","volume":"56","author":"YW Jin","year":"2024","unstructured":"Jin YW, Ma YR, Zhang MK et al (2024) Identification and characterization of endogenous biomarkers for hepatic vectorial transport (OATP1B3-P-gp) function using metabolomics with serum pharmacology. Amino Acids 56(1):11. https:\/\/doi.org\/10.1007\/s00726-023-03363-5","journal-title":"Amino Acids"},{"issue":"10","key":"4534_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.18632\/aging.100203","volume":"2","author":"TC Karagiannis","year":"2010","unstructured":"Karagiannis TC, Lin AJ, Ververis K et al (2010) Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. Aging (Albany NY) 2(10):659\u2013668. https:\/\/doi.org\/10.18632\/aging.100203","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"4534_CR30","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1021\/jm300212s","volume":"55","author":"M Karlgren","year":"2012","unstructured":"Karlgren M, Vildhede A, Norinder U et al (2012) Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. J Med Chem 55(10):4740\u20134763. https:\/\/doi.org\/10.1021\/jm300212s","journal-title":"J Med Chem"},{"issue":"10","key":"4534_CR31","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1124\/dmd.108.022251","volume":"36","author":"N Kassner","year":"2008","unstructured":"Kassner N, Huse K, Martin HJ et al (2008) Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab Dispos 36(10):2113\u20132120. https:\/\/doi.org\/10.1124\/dmd.108.022251","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"4534_CR32","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.48309\/jmpcr.2025.471206.1367","volume":"7","author":"D Khairani","year":"2025","unstructured":"Khairani D, Ilyas S (2025) Flavonoids for hepatoprotection: potential natural approaches to mitigate doxorubicin-induced liver toxicity: a mini review. J Med Pharm Chem Res 7(7):1464\u20131485. https:\/\/doi.org\/10.48309\/jmpcr.2025.471206.1367","journal-title":"J Med Pharm Chem Res"},{"key":"4534_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262010130","author":"M Kosi\u0107","year":"2025","unstructured":"Kosi\u0107 M, Pajovi\u0107 V, Jovanovi\u0107 M, Japund\u017ei\u0107-\u017digon N (2025) Drug repositioning in doxorubicin-induced cardiotoxicity protection. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms262010130","journal-title":"Int J Mol Sci"},{"key":"4534_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030568","author":"Z Kuang","year":"2023","unstructured":"Kuang Z, Wu J, Tan Y, Zhu G, Li J, Wu M (2023) MicroRNA in the diagnosis and treatment of doxorubicin-induced cardiotoxicity. Biomolecules. https:\/\/doi.org\/10.3390\/biom13030568","journal-title":"Biomolecules"},{"issue":"17","key":"4534_CR35","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1093\/cvr\/cvac026","volume":"118","author":"A Kuno","year":"2023","unstructured":"Kuno A, Hosoda R, Tsukamoto M et al (2023) SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX. Cardiovasc Res 118(17):3360\u20133373. https:\/\/doi.org\/10.1093\/cvr\/cvac026","journal-title":"Cardiovasc Res"},{"issue":"3","key":"4534_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1124\/dmd.108.023630","volume":"37","author":"M Le Vee","year":"2009","unstructured":"Le Vee M, Lecureur V, Stieger B, Fardel O (2009) Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos 37(3):685\u2013693. https:\/\/doi.org\/10.1124\/dmd.108.023630","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"4534_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5487\/tr.2014.30.4.243","volume":"30","author":"S Lee","year":"2014","unstructured":"Lee S, Kim JS (2014) Mitophagy: therapeutic potentials for liver disease and beyond. Toxicol Res 30(4):243\u2013250. https:\/\/doi.org\/10.5487\/tr.2014.30.4.243","journal-title":"Toxicol Res"},{"key":"4534_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940867","volume":"13","author":"W Li","year":"2022","unstructured":"Li W, Chang N, Li L (2022) Heterogeneity and function of Kupffer cells in liver injury. Front Immunol 13:940867. https:\/\/doi.org\/10.3389\/fimmu.2022.940867","journal-title":"Front Immunol"},{"issue":"6","key":"4534_CR39","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i6.106932","volume":"17","author":"SF Li","year":"2025","unstructured":"Li SF, Ouyang X, Feng S et al (2025a) Oncohepatology: navigating liver injury in the era of modern cancer therapy. World J Hepatol 17(6):106932. https:\/\/doi.org\/10.4254\/wjh.v17.i6.106932","journal-title":"World J Hepatol"},{"key":"4534_CR40","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19887","volume":"13","author":"X Li","year":"2025","unstructured":"Li X, Zhang Z, Han Y, Zhang M (2025b) NLRP3 inflammasome and pyroptosis: implications in inflammation and multisystem disorders. PeerJ 13:e19887. https:\/\/doi.org\/10.7717\/peerj.19887","journal-title":"PeerJ"},{"key":"4534_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biom14040422","author":"J Liu","year":"2024","unstructured":"Liu J, Liu H, Deng L et al (2024) Protective role of dioscin against doxorubicin-induced chronic cardiotoxicity: insights from Nrf2-GPX4 axis-mediated cardiac ferroptosis. Biomolecules. https:\/\/doi.org\/10.3390\/biom14040422","journal-title":"Biomolecules"},{"key":"4534_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1633315","volume":"16","author":"D Liu","year":"2025","unstructured":"Liu D, Li M, Liang Y, Xu F, Li R, Sun Y (2025) Immune microenvironment regulation and clinical immunotherapy strategies of metastatic liver cancer. Front Immunol 16:1633315. https:\/\/doi.org\/10.3389\/fimmu.2025.1633315","journal-title":"Front Immunol"},{"issue":"8","key":"4534_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23798","volume":"38","author":"N \u00d6zturk","year":"2024","unstructured":"\u00d6zturk N, Ceylan H, Demir Y (2024) The hepatoprotective potential of tannic acid against doxorubicin-induced hepatotoxicity: insights into its antioxidative, anti-inflammatory, and antiapoptotic mechanisms. J Biochem Mol Toxicol 38(8):e23798. https:\/\/doi.org\/10.1002\/jbt.23798","journal-title":"J Biochem Mol Toxicol"},{"issue":"5","key":"4534_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152090","volume":"11","author":"C Pan","year":"2016","unstructured":"Pan C, Wang X, Shi K et al (2016) MiR-122 reverses the doxorubicin-resistance in hepatocellular carcinoma cells through regulating the tumor metabolism. PLoS ONE 11(5):e0152090. https:\/\/doi.org\/10.1371\/journal.pone.0152090","journal-title":"PLoS ONE"},{"key":"4534_CR45","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/ncomms2921","volume":"4","author":"B Pang","year":"2013","unstructured":"Pang B, Qiao X, Janssen L et al (2013) Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat Commun 4:1908. https:\/\/doi.org\/10.1038\/ncomms2921","journal-title":"Nat Commun"},{"issue":"3","key":"4534_CR46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1158\/2159-8290.Cd-21-0922","volume":"12","author":"R Pillai","year":"2022","unstructured":"Pillai R, Hayashi M, Zavitsanou AM, Papagiannakopoulos T (2022) NRF2: KEAPing tumors protected. Cancer Discov 12(3):625\u2013643. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0922","journal-title":"Cancer Discov"},{"key":"4534_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113231","volume":"185","author":"LF Pippa","year":"2020","unstructured":"Pippa LF, Oliveira MLd, Rocha A, de Andrade JM, Lanchote VL (2020) Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. J Pharm Biomed Anal 185:113231. https:\/\/doi.org\/10.1016\/j.jpba.2020.113231","journal-title":"J Pharm Biomed Anal"},{"key":"4534_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117599","volume":"250","author":"PL Prasanna","year":"2020","unstructured":"Prasanna PL, Renu K, Valsala Gopalakrishnan A (2020) New molecular and biochemical insights of doxorubicin-induced hepatotoxicity. Life Sci 250:117599. https:\/\/doi.org\/10.1016\/j.lfs.2020.117599","journal-title":"Life Sci"},{"key":"4534_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30153311","author":"L Radeva","year":"2025","unstructured":"Radeva L, Yoncheva K (2025) Doxorubicin toxicity and recent approaches to alleviating its adverse effects with focus on oxidative stress. Molecules. https:\/\/doi.org\/10.3390\/molecules30153311","journal-title":"Molecules"},{"issue":"3","key":"4534_CR50","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/ijms23031286","volume":"23","author":"D Rodrigues","year":"2022","unstructured":"Rodrigues D, Coyle L, F\u00fczi B et al (2022) Unravelling mechanisms of doxorubicin-induced toxicity in 3D human intestinal organoids. Int J Mol Sci 23(3):1286","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4534_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2022.103308","volume":"29","author":"DO Saleh","year":"2022","unstructured":"Saleh DO, Mahmoud SS, Hassan A, Sanad EF (2022) Doxorubicin-induced hepatic toxicity in rats: mechanistic protective role of Omega-3 fatty acids through Nrf2\/HO-1 activation and PI3K\/Akt\/GSK-3\u03b2 axis modulation. Saudi J Biol Sci 29(7):103308. https:\/\/doi.org\/10.1016\/j.sjbs.2022.103308","journal-title":"Saudi J Biol Sci"},{"key":"4534_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.969363","volume":"13","author":"RD Schnegelberger","year":"2022","unstructured":"Schnegelberger RD, Steiert B, Sandoval PJ, Hagenbuch B (2022) Using a competitive counterflow assay to identify novel cationic substrates of OATP1B1 and OATP1B3. Front Physiol 13:969363. https:\/\/doi.org\/10.3389\/fphys.2022.969363","journal-title":"Front Physiol"},{"issue":"4","key":"4534_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaccao.2025.04.002","volume":"7","author":"P Sep\u00falveda","year":"2025","unstructured":"Sep\u00falveda P (2025) Synergistic miRNA combinations mitigate doxorubicin-induced cardiotoxicity: Are we ready for clinical translation? JACC CardioOncol 7(4):411\u2013413. https:\/\/doi.org\/10.1016\/j.jaccao.2025.04.002","journal-title":"JACC CardioOncol"},{"issue":"7575","key":"4534_CR54","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K et al (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660\u2013665. https:\/\/doi.org\/10.1038\/nature15514","journal-title":"Nature"},{"issue":"1","key":"4534_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40360-025-00932-0","volume":"26","author":"A Soltani Hekmat","year":"2025","unstructured":"Soltani Hekmat A, Hekmat M, Ramezanipour S, Javanmardi K (2025) Protective effects of Alamandine against doxorubicin-induced liver injury in rats. BMC Pharmacol Toxicol 26(1):95. https:\/\/doi.org\/10.1186\/s40360-025-00932-0","journal-title":"BMC Pharmacol Toxicol"},{"key":"4534_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01030","volume":"10","author":"S Song","year":"2019","unstructured":"Song S, Chu L, Liang H et al (2019) Protective effects of Dioscin against doxorubicin-induced hepatotoxicity via regulation of Sirt1\/FOXO1\/NF-\u03bab signal. Front Pharmacol 10:1030. https:\/\/doi.org\/10.3389\/fphar.2019.01030","journal-title":"Front Pharmacol"},{"issue":"3","key":"4534_CR57","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3350\/cmh.2021.0308","volume":"28","author":"PS Sung","year":"2022","unstructured":"Sung PS (2022) Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma. Clin Mol Hepatol 28(3):333\u2013350. https:\/\/doi.org\/10.3350\/cmh.2021.0308","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"4534_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","volume":"65","author":"O Tacar","year":"2013","unstructured":"Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2):157\u2013170. https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01567.x","journal-title":"J Pharm Pharmacol"},{"key":"4534_CR59","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132747","author":"T Tadokoro","year":"2020","unstructured":"Tadokoro T, Ikeda M, Ide T et al (2020) Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.132747","journal-title":"JCI Insight"},{"key":"4534_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114489","volume":"153","author":"B Tang","year":"2025","unstructured":"Tang B, Ouyang H, Zheng S et al (2025) Doxorubicin promotes NK cell dysfunction and induces acute liver injury through kynurenine-AhR axis. Int Immunopharmacol 153:114489. https:\/\/doi.org\/10.1016\/j.intimp.2025.114489","journal-title":"Int Immunopharmacol"},{"key":"4534_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051261","author":"L Tietze","year":"2020","unstructured":"Tietze L, Kessler SM (2020) The good, the bad, the question-H19 in hepatocellular carcinoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12051261","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4534_CR62","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.28389","volume":"63","author":"AC Tosello-Trampont","year":"2016","unstructured":"Tosello-Trampont AC, Krueger P, Narayanan S, Landes SG, Leitinger N, Hahn YS (2016) NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice. Hepatology 63(3):799\u2013812. https:\/\/doi.org\/10.1002\/hep.28389","journal-title":"Hepatology"},{"issue":"7","key":"4534_CR63","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/circresaha.119.314681","volume":"126","author":"KB Wallace","year":"2020","unstructured":"Wallace KB, Sard\u00e3o VA, Oliveira PJ (2020) Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ Res 126(7):926\u2013941. https:\/\/doi.org\/10.1161\/circresaha.119.314681","journal-title":"Circ Res"},{"issue":"1","key":"4534_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/ol.2025.15386","volume":"31","author":"Y Wang","year":"2026","unstructured":"Wang Y, Zhang C, Wang H et al (2026) Research progress on neutrophil extracellular traps and hepatitis-to-hepatocellular carcinoma transformation (review). Oncol Lett 31(1):33. https:\/\/doi.org\/10.3892\/ol.2025.15386","journal-title":"Oncol Lett"},{"issue":"6","key":"4534_CR65","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jacbts.2023.10.009","volume":"9","author":"L Wu","year":"2024","unstructured":"Wu L, Zhang Y, Wang G, Ren J (2024) Molecular mechanisms and therapeutic targeting of ferroptosis in doxorubicin-induced cardiotoxicity. JACC Basic Transl Sci 9(6):811\u2013826. https:\/\/doi.org\/10.1016\/j.jacbts.2023.10.009","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"4534_CR66","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/bioengineering12040430","volume":"12","author":"W Xia","year":"2025","unstructured":"Xia W, King MW (2025) Advances in targeted delivery of doxorubicin for cancer chemotherapy. Bioengineering (Basel) 12(4):430","journal-title":"Bioengineering (Basel)"},{"issue":"33","key":"4534_CR67","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.3748\/wjg.v30.i33.3791","volume":"30","author":"ZY Xing","year":"2024","unstructured":"Xing ZY, Zhang CJ, Liu LJ (2024) Targeting both ferroptosis and pyroptosis may represent potential therapies for acute liver failure. World J Gastroenterol 30(33):3791\u20133798. https:\/\/doi.org\/10.3748\/wjg.v30.i33.3791","journal-title":"World J Gastroenterol"},{"key":"4534_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tiv.2018.05.001","volume":"51","author":"J Yin","year":"2018","unstructured":"Yin J, Guo J, Zhang Q et al (2018) Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1\/parkin pathway. Toxicol in Vitro 51:1\u201310. https:\/\/doi.org\/10.1016\/j.tiv.2018.05.001","journal-title":"Toxicol in Vitro"},{"issue":"8","key":"4534_CR69","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41401-024-01239-2","volume":"45","author":"FL Zeng","year":"2024","unstructured":"Zeng FL, Zhang Y, Wang ZH et al (2024) Neutrophil extracellular traps promote acetaminophen-induced acute liver injury in mice via AIM2. Acta Pharmacol Sin 45(8):1660\u20131672. https:\/\/doi.org\/10.1038\/s41401-024-01239-2","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"4534_CR70","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/cai2.7","volume":"1","author":"C Zhang","year":"2022","unstructured":"Zhang C, Yu JJ, Yang C et al (2022) Crosstalk between ferroptosis and stress-implications in cancer therapeutic responses. Cancer Innov 1(1):92\u2013113. https:\/\/doi.org\/10.1002\/cai2.7","journal-title":"Cancer Innov"},{"key":"4534_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121614","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xie S, Deng W (2024) Mitophagy in doxorubicin-induced cardiotoxicity: insights into molecular biology and novel therapeutic strategies. Biomolecules. https:\/\/doi.org\/10.3390\/biom14121614","journal-title":"Biomolecules"},{"key":"4534_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104276","volume":"146","author":"X Zhao","year":"2019","unstructured":"Zhao X, Jin Y, Li L et al (2019) MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1. Pharmacol Res 146:104276. https:\/\/doi.org\/10.1016\/j.phrs.2019.104276","journal-title":"Pharmacol Res"},{"key":"4534_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1567312","volume":"16","author":"XP Zhao","year":"2025","unstructured":"Zhao XP, Duan L, Zhao QR et al (2025) NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: role of phytochemicals. Front Pharmacol 16:1567312. https:\/\/doi.org\/10.3389\/fphar.2025.1567312","journal-title":"Front Pharmacol"},{"key":"4534_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1462512","volume":"15","author":"H Zhu","year":"2024","unstructured":"Zhu H, Chen H, Zhu X, Zhang B, Jin C (2024) Diagnostic lncRNA high expression for liver patients prognosis and medication guidance: a systematic review and meta-analysis. Front Pharmacol 15:1462512. https:\/\/doi.org\/10.3389\/fphar.2024.1462512","journal-title":"Front Pharmacol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04534-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04534-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04534-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:23:22Z","timestamp":1789647802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04534-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":74,"alternative-id":["4534"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04534-5","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}